$356 Million is the total value of Affinity Asset Advisors, LLC's 81 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 81.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | APOGEE THERAPEUTICS INC | $22,260,843 | – | 1,045,110 | +100.0% | 6.26% | – | |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $20,400,000 | +69.3% | 2,000,000 | +25.0% | 5.74% | +36.4% |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $16,838,996 | +46.4% | 1,129,376 | +7.5% | 4.74% | +18.0% |
| Buy | BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $16,407,550 | +73.6% | 17,000,000 | +41.7% | 4.62% | +39.8% | |
| CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $14,954,882 | -14.5% | 685,061 | +24.6% | 4.21% | -31.1% |
| Buy | ARCELLX INC | $14,352,000 | +100.6% | 400,000 | +76.8% | 4.04% | +61.5% | |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $13,383,000 | – | 450,000 | +100.0% | 3.76% | – |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $12,413,400 | -41.9% | 85,000 | -8.1% | 3.49% | -53.2% |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $11,733,030 | -19.2% | 239,108 | +13.0% | 3.30% | -34.9% |
| IMVT | Buy | IMMUNOVANT INC | $11,517,000 | +133.5% | 300,000 | +15.4% | 3.24% | +88.0% |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDcall | $11,220,000 | – | 1,100,000 | +100.0% | 3.16% | – |
| XENE | Buy | XENON PHARMACEUTICALS INC | $10,262,962 | +341.5% | 300,438 | +397.6% | 2.89% | +255.5% |
| KURA | Sell | KURA ONCOLOGY INC | $7,811,599 | -18.9% | 856,535 | -5.9% | 2.20% | -34.7% |
| Buy | ASTRIA THERAPEUTICS INC | $7,462,238 | +37.6% | 1,000,300 | +53.7% | 2.10% | +10.8% | |
| ARKG | New | ARK ETF TRput | $6,965,000 | – | 250,000 | +100.0% | 1.96% | – |
| ESTA | New | ESTABLISHMENT LABS HLDGS INCcall | $6,869,800 | – | 140,000 | +100.0% | 1.93% | – |
| CYTK | Buy | CYTOKINETICS INC | $6,786,582 | +66.2% | 230,366 | +84.1% | 1.91% | +33.9% |
| KRYS | New | KRYSTAL BIOTECH INC | $6,670,000 | – | 57,500 | +100.0% | 1.88% | – |
| CNTA | Buy | CENTESSA PHARMACEUTICALS PLCsponsored ads | $6,587,049 | +18.1% | 1,018,091 | +13.0% | 1.85% | -4.8% |
| MORF | Buy | MORPHIC HLDG INC | $6,185,700 | -46.6% | 270,000 | +33.7% | 1.74% | -57.0% |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $6,003,763 | -36.6% | 368,329 | -17.7% | 1.69% | -48.9% |
| INZY | Buy | INOZYME PHARMA INC | $5,795,378 | +38.4% | 1,379,852 | +83.5% | 1.63% | +11.4% |
| ALKS | New | ALKERMES PLCcall | $5,602,000 | – | 200,000 | +100.0% | 1.58% | – |
| APLS | New | APELLIS PHARMACEUTICALS INCput | $4,945,200 | – | 130,000 | +100.0% | 1.39% | – |
| IMVT | New | IMMUNOVANT INCput | $4,917,759 | – | 128,100 | +100.0% | 1.38% | – |
| AUTL | Buy | AUTOLUS THERAPEUTICS PLCspon ads | $4,642,446 | +22.8% | 1,992,466 | +25.4% | 1.31% | -1.1% |
| SVRA | New | SAVARA INC | $4,347,000 | – | 1,150,000 | +100.0% | 1.22% | – |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $4,344,896 | -15.7% | 46,400 | -19.7% | 1.22% | -32.1% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $4,128,000 | +39.8% | 150,000 | +72.4% | 1.16% | +12.6% |
| AZN | ASTRAZENECA PLCsponsored adr | $4,063,200 | -5.4% | 60,000 | 0.0% | 1.14% | -23.8% | |
| New | TANGO THERAPEUTICS INC | $3,941,000 | – | 350,000 | +100.0% | 1.11% | – | |
| PRTA | Sell | PROTHENA CORP PLC | $3,822,076 | -44.0% | 79,214 | -20.8% | 1.08% | -54.9% |
| VKTX | Sell | VIKING THERAPEUTICS INCput | $3,681,882 | -35.1% | 332,600 | -5.0% | 1.04% | -47.7% |
| MRSN | New | MERSANA THERAPEUTICS INC | $3,619,500 | – | 2,850,000 | +100.0% | 1.02% | – |
| VKTX | VIKING THERAPEUTICS INC | $3,321,000 | -31.7% | 300,000 | 0.0% | 0.93% | -45.0% | |
| New | AEGLEA BIOTHERAPEUTICS INC | $2,968,138 | – | 242,297 | +100.0% | 0.84% | – | |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $2,954,000 | – | 200,000 | +100.0% | 0.83% | – |
| New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $2,850,000 | – | 50,000 | +100.0% | 0.80% | – | |
| ALKS | New | ALKERMES PLC | $2,801,000 | – | 100,000 | +100.0% | 0.79% | – |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $2,679,952 | +67.0% | 278,292 | +56.1% | 0.75% | +34.6% |
| MRTX | New | MIRATI THERAPEUTICS INC | $2,632,157 | – | 60,426 | +100.0% | 0.74% | – |
| IMTX | Sell | IMMATICS N.V | $2,316,000 | -33.1% | 200,000 | -33.3% | 0.65% | -46.2% |
| New | NUVALENT INC | $2,298,500 | – | 50,000 | +100.0% | 0.65% | – | |
| SGEN | New | SEAGEN INC | $2,121,500 | – | 10,000 | +100.0% | 0.60% | – |
| LNTH | New | LANTHEUS HLDGS INC | $2,084,400 | – | 30,000 | +100.0% | 0.59% | – |
| NRIX | Buy | NURIX THERAPEUTICS INC | $1,965,000 | +96.7% | 250,000 | +150.0% | 0.55% | +58.5% |
| ACRS | New | ACLARIS THERAPEUTICS INCput | $1,781,000 | – | 260,000 | +100.0% | 0.50% | – |
| New | ROIVANT SCIENCES LTD | $1,752,000 | – | 150,000 | +100.0% | 0.49% | – | |
| TERN | New | TERNS PHARMACEUTICALS INC | $1,634,750 | – | 325,000 | +100.0% | 0.46% | – |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $1,521,600 | +67.0% | 40,000 | +300.0% | 0.43% | +34.6% |
| PCVX | Buy | VAXCYTE INC | $1,274,500 | +83.3% | 25,000 | +79.6% | 0.36% | +47.7% |
| INSP | New | INSPIRE MED SYS INC | $1,248,783 | – | 6,293 | +100.0% | 0.35% | – |
| EYPT | New | EYEPOINT PHARMACEUTICALS INCput | $1,238,450 | – | 155,000 | +100.0% | 0.35% | – |
| Buy | NEWAMSTERDAM PHARMA COMPANYordinary shares | $1,156,250 | -2.8% | 125,000 | +25.0% | 0.32% | -21.7% | |
| MORF | New | MORPHIC HLDG INCput | $1,145,500 | – | 50,000 | +100.0% | 0.32% | – |
| TALS | Buy | TALARIS THERAPEUTICS INC | $1,124,000 | +84.9% | 400,000 | +100.0% | 0.32% | +49.1% |
| Buy | THESEUS PHARMACEUTICALS INC | $1,077,953 | -51.9% | 400,726 | +66.8% | 0.30% | -61.3% | |
| MIST | Buy | MILESTONE PHARMACEUTICALS IN | $1,038,711 | +21.5% | 335,068 | +11.7% | 0.29% | -2.3% |
| Sell | LIANBIOsponsored ads | $1,001,812 | -45.1% | 672,357 | -16.0% | 0.28% | -55.8% | |
| ADCT | Buy | ADC THERAPEUTICS SA | $986,700 | -23.5% | 1,100,000 | +83.3% | 0.28% | -38.4% |
| IFRX | Buy | INFLARX NV | $968,789 | -9.6% | 325,097 | +35.3% | 0.27% | -27.0% |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $961,353 | -71.8% | 41,581 | -68.0% | 0.27% | -77.3% |
| MIRM | MIRUM PHARMACEUTICALS INC | $948,000 | +22.1% | 30,000 | 0.0% | 0.27% | -1.5% | |
| TVTX | New | TRAVERE THERAPEUTICS INC | $894,000 | – | 100,000 | +100.0% | 0.25% | – |
| PODD | New | INSULET CORP | $797,450 | – | 5,000 | +100.0% | 0.22% | – |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $791,100 | +30.9% | 30,000 | -14.6% | 0.22% | +5.7% |
| New | BIOHAVEN LTD | $784,358 | – | 30,156 | +100.0% | 0.22% | – | |
| AVRO | New | AVROBIO INC | $770,000 | – | 500,000 | +100.0% | 0.22% | – |
| IMTXW | IMMATICS N.V*w exp 07/01/202 | $662,702 | +4.7% | 187,204 | 0.0% | 0.19% | -15.8% | |
| ETNB | New | 89BIO INCcall | $575,912 | – | 37,300 | +100.0% | 0.16% | – |
| PBYI | PUMA BIOTECHNOLOGY INC | $532,178 | -25.5% | 202,349 | 0.0% | 0.15% | -39.8% | |
| New | PROMIS NEUROSCIENCES INC | $526,677 | – | 265,958 | +100.0% | 0.15% | – | |
| Buy | CONTEXT THERAPEUTICS INC | $496,514 | +16.0% | 328,817 | +22.9% | 0.14% | -6.7% | |
| MESO | New | MESOBLAST LTDput | $492,000 | – | 400,000 | +100.0% | 0.14% | – |
| NUVB | NUVATION BIO INC | $335,000 | -25.6% | 250,000 | 0.0% | 0.09% | -40.1% | |
| BCAB | Sell | BIOATLA INC | $306,000 | -68.6% | 180,000 | -44.6% | 0.09% | -74.8% |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $296,245 | -76.5% | 44,348 | -70.4% | 0.08% | -81.1% |
| Buy | NEWAMSTERDAM PHARMA COMPANY*w exp 11/22/202 | $260,300 | +236.6% | 137,000 | +270.3% | 0.07% | +170.4% | |
| NLSP | Sell | NLS PHARMACEUTICS LTD | $140,319 | -68.1% | 200,455 | -49.9% | 0.04% | -74.7% |
| ARAV | New | ARAVIVE INC | $45,739 | – | 346,511 | +100.0% | 0.01% | – |
| ROCKET PHARMACEUTICALS INC*w exp 09/02/202 | $7,500 | -46.1% | 75,000 | 0.0% | 0.00% | -60.0% | ||
| ARAV | Exit | ARAVIVE INCcall | $0 | – | -33,600 | -100.0% | -0.02% | – |
| VIR | Exit | VIR BIOTECHNOLOGY INC | $0 | – | -20,000 | -100.0% | -0.17% | – |
| Exit | JASPER THERAPEUTICS INC | $0 | – | -476,948 | -100.0% | -0.23% | – | |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -12,500 | -100.0% | -0.31% | – |
| FGEN | Exit | FIBROGEN INCcall | $0 | – | -340,000 | -100.0% | -0.32% | – |
| Exit | MINERALYS THERAPEUTICS INC | $0 | – | -62,500 | -100.0% | -0.37% | – | |
| ARAV | Exit | ARAVIVE INCput | $0 | – | -861,200 | -100.0% | -0.38% | – |
| ALPN | Exit | ALPINE IMMUNE SCIENCES INC | $0 | – | -118,891 | -100.0% | -0.43% | – |
| Exit | AADI BIOSCIENCE INC | $0 | – | -187,675 | -100.0% | -0.45% | – | |
| Exit | PRECIGEN INCnote 3.500% 7/0 | $0 | – | -1,500,000 | -100.0% | -0.53% | – | |
| CABA | Exit | CABALETTA BIO INC | $0 | – | -125,000 | -100.0% | -0.56% | – |
| VINC | Exit | VINCERX PHARMA INC | $0 | – | -1,492,771 | -100.0% | -0.68% | – |
| AGLE | Exit | AEGLEA BIOTHERAPEUTICS INC | $0 | – | -4,900,000 | -100.0% | -0.77% | – |
| FGEN | Exit | FIBROGEN INC | $0 | – | -983,300 | -100.0% | -0.93% | – |
| FGEN | Exit | FIBROGEN INCput | $0 | – | -983,300 | -100.0% | -0.93% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -29,105 | -100.0% | -1.04% | – |
| VRDN | Exit | VIRIDIAN THERAPEUTICS INCcall | $0 | – | -130,400 | -100.0% | -1.08% | – |
| Exit | VENTYX BIOSCIENCES INC | $0 | – | -100,696 | -100.0% | -1.15% | – | |
| Exit | ESPERION THERAPEUTICS INC NEnote 4.000%11/1 | $0 | – | -6,925,000 | -100.0% | -1.20% | – | |
| BBIO | Exit | BRIDGEBIO PHARMA INCput | $0 | – | -376,000 | -100.0% | -2.26% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -40,000 | -100.0% | -3.98% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INCcall | $0 | – | -53,100 | -100.0% | -4.28% | – |
| KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -321,017 | -100.0% | -4.31% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MORPHIC HOLDING INC | 12 | Q3 2023 | 6.9% |
| KURA ONCOLOGY INC | 12 | Q3 2023 | 7.2% |
| CELLDEX THERAPEUTICS INC NEW | 12 | Q3 2023 | 1.9% |
| IMMATICS N.V | 12 | Q3 2023 | 0.4% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.4% |
| ESTABLISHMENT LABS HLDGS INC | 11 | Q3 2023 | 8.3% |
| VINCERX PHARMA INC | 11 | Q2 2023 | 4.5% |
| ASCENDIS PHARMA A/S | 11 | Q3 2023 | 4.9% |
| CYTOKINETICS INC | 11 | Q3 2023 | 2.6% |
| INARI MED INC | 10 | Q1 2023 | 6.4% |
View Affinity Asset Advisors, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | July 03, 2023 | 7,477,000 | 9.2% |
View Affinity Asset Advisors, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-21 |
| 13F-HR | 2023-08-14 |
| SC 13G | 2023-07-03 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-13 |
View Affinity Asset Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.